Cargando…
Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
Autores principales: | Mann, Minakshi, Kumar, Sachin, Chauhan, Shyam S., Bhatla, Neerja, Kumar, Sunesh, Bakhshi, Sameer, Gupta, Ritu, Sharma, Ashok, Kumar, Lalit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677665/ https://www.ncbi.nlm.nih.gov/pubmed/31413820 http://dx.doi.org/10.18632/oncotarget.27101 |
Ejemplares similares
-
PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019) -
Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern
por: Dhamija, Ekta, et al.
Publicado: (2021) -
Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020) -
Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting
por: Dhamija, Ekta, et al.
Publicado: (2021) -
Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway
por: Das, Abhijit, et al.
Publicado: (2023)